SCHEMBL20071875

SCHEMBL20071875

CC(C)(C)OC(=O)N1CCC(COCO)CC1

nearest known ligand 0.56

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.50
KDM4E B2RXH2 1/20 0.49
PKM P14618 1/20 0.49
GPR119 Q8TDV5 8/20 0.48
RECQL P46063 1/20 0.48
EPHX1 P07099 1/20 0.48
NR1H2 P55055 1/20 0.48
USP2 O75604 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
FAAH O00519 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL796239 0.90 HPGD (0.53) HPGDKDM4EPKMGPR119RECQL
SCHEMBL21998064 0.88 HPGD (0.48) HPGDKDM4EPKMGPR119RECQL
SCHEMBL2149045 0.88 GPR119 (0.51) HPGDKDM4EPKMGPR119RECQL
SCHEMBL4227407 0.87 GPR119 (0.48) HPGDKDM4EPKMGPR119RECQL
SCHEMBL25308738 0.85 KDM4E (0.50) HPGDKDM4EPKMGPR119RECQL
SCHEMBL13871730 0.85 HPGD (0.48) HPGDKDM4EPKMGPR119RECQL
SCHEMBL795969 0.84 HPGD (0.53) HPGDKDM4EPKMGPR119RECQL
SCHEMBL21997138 0.84 HPGD (0.47) HPGDKDM4EPKMGPR119RECQL
SCHEMBL22126882 0.84 HPGD (0.47) HPGDKDM4EPKMGPR119RECQL
SCHEMBL795771 0.84 HPGD (0.47) HPGDKDM4EPKMGPR119RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018071313-A1 N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR BETA AGONISTS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2018-04-19 WO disclosed
WO-2018068297-A1 N-ARYL AND N-HETEROARYL PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE MERCK SHARP & DOHME CORP. (US) 2018-04-19 WO disclosed